Dual antiplatelet therapy (DAPT) prescribing practice among cardiologists: a survey of practice
3rd October 2019
Dear BCIS members
An NIHR funded study in Bristol is being undertaken to look retrospectively at ‘real-world’ bleeding rates in patients treated with dual antiplatelet therapy (DAPT). As part of this project Bristol have undertaken some qualitative research with prescribers and patients. As an extension to this work, Bristol would be very interested to obtain a better understanding of the factors that influence your prescribing of DAPT to patients presenting with acute coronary syndrome (ACS).
Participation is voluntary and the survey will take 15-20 minutes to complete. Your responses are confidential, however, in acknowledgement of the time spent completing this survey, you are invited to enter a prize draw to win a 10.5-inch iPad Pro 64GB. If you wish to enter the prize draw please leave your email address at the end of the survey. The winner will be notified by email. All data will be stored in a password protected electronic format. Once the prize draw is complete, the team from Bristol will permanently delete the email address you provided.
Please follow the link: https://www.surveymonkey.co.uk/r/2XKY3KD
If you have any questions about the research study, please contact Dr Tom Johnson, Email: firstname.lastname@example.org
Prof Nick Curzen
Lead, BCIS R&D Committee